Ftse Mib
34.307,84
0,36%
DAX
19.983,25
0,37%
S&P 500
5.896,92
0,26%
NASDAQ
19.346,86
0,19%
Bitcoin
97.229,20
3,01%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Intra Cellular Therapies Inc (ITCI) Intra Cellular Therapies Inc (ITCI) Notizie

Intra Cellular Therapies Inc

ITCI
84,52
1,00 (1,20%)
Ultimo aggiornamento: 17:16:56
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
11/12/202414:00GLOBEIntra-Cellular Therapies Presents Data from the CAPLYTA..
07/12/202400:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202422:27EDGAR2Form 144 - Report of proposed sale of securities
04/12/202422:18EDGAR2Form 144 - Report of proposed sale of securities
03/12/202413:38EDGAR2Form 8-K - Current report
03/12/202413:30GLOBEIntra-Cellular Therapies Submits Supplemental New Drug..
19/11/202414:00GLOBEIntra-Cellular Therapies to Participate in Three Upcoming..
08/11/202423:31EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
07/11/202414:00GLOBEIntra-Cellular Therapies Announces Presentations at the 2024..
05/11/202413:10EDGAR2Form 8-K - Current report
05/11/202413:00GLOBEIntra-Cellular Therapies Announces Positive Topline Results..
30/10/202412:53EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
30/10/202412:44EDGAR2Form 8-K - Current report
30/10/202412:30GLOBEIntra-Cellular Therapies Reports Third Quarter 2024..
17/10/202414:00GLOBEIntra-Cellular Therapies to Host Third Quarter 2024..
23/9/202414:00GLOBEIntra-Cellular Therapies Announces Presentations at the 2024..
06/9/202423:43EDGAR2Form 144 - Report of proposed sale of securities
31/8/202400:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/8/202422:06EDGAR2Form 144 - Report of proposed sale of securities
29/8/202422:34EDGAR2Form 144 - Report of proposed sale of securities
29/8/202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/8/202422:34EDGAR2Form 144 - Report of proposed sale of securities
28/8/202414:00GLOBEIntra-Cellular Therapies to Present at Three Upcoming..
27/8/202422:22EDGAR2Form 144 - Report of proposed sale of securities
26/8/202422:36EDGAR2Form 144 - Report of proposed sale of securities
24/8/202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/8/202422:14EDGAR2Form 144 - Report of proposed sale of securities
22/8/202422:09EDGAR2Form 144 - Report of proposed sale of securities
21/8/202422:25EDGAR2Form 144 - Report of proposed sale of securities
21/8/202400:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/8/202422:04EDGAR2Form 144 - Report of proposed sale of securities
15/8/202400:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/8/202400:00EDGAR2Form 3 - Initial statement of beneficial ownership of..
08/8/202414:00GLOBEIntra-Cellular Therapies to Present at the Canaccord Genuity..
07/8/202413:55EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/8/202413:49EDGAR2Form 8-K - Current report
07/8/202413:40GLOBEIntra-Cellular Therapies Announces Appointment of Sanjeev..
07/8/202413:30GLOBEIntra-Cellular Therapies Reports Second Quarter 2024..
24/7/202414:00GLOBEIntra-Cellular Therapies to Host Second Quarter 2024..
19/6/202400:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/6/202422:16EDGAR2Form 8-K - Current report
18/6/202413:37EDGAR2Form 8-K - Current report
18/6/202413:30GLOBEIntra-Cellular Therapies Announces Positive Topline Results..
10/6/202414:00GLOBEIntra-Cellular Therapies to Present at the 45th Annual..
29/5/202414:00GLOBEIntra-Cellular Therapies to Present at the Jefferies Global..
23/5/202414:00GLOBEIntra-Cellular Therapies Highlights Data Presentations at..
08/5/202414:00GLOBEIntra-Cellular Therapies to Participate in Two Upcoming..
07/5/202413:43EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/5/202413:40EDGAR2Form 8-K - Current report
07/5/202413:30GLOBEIntra-Cellular Therapies Reports First Quarter 2024..
Apertura: 84,16 Min: 83,75 Max: 84,99
Chiusura: 83,52

La tua Cronologia

NASDAQ
ITCI
Intra Cellular Therapies
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network